Voice your opinion on congressional bill S5002-117 and let lawmakers know your stance with UnPac!

Main Subject: Health

FDA Modernization Act 2.0

This bill authorizes the use of certain alternatives to animal testing, including cell-based assays and computer models, to obtain an exemption from the Food and Drug Administration to investigate the safety and effectiveness of a drug.

The bill also removes a requirement to use animal studies as part of the process to obtain a license for a biological product that is biosimilar or interchangeable with another biological product.

S4348-117, S4288-117,

House floor actions Actions

Floor
Sep. 29 2022	Held at the desk. Received in the House.

Senate Actions

Floor
Sep. 29 2022	Message on Senate action sent to the House. Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Unanimous Consent. (consideration: CR S5514-5515; text: CR S5514-5515)

Library of Congress Actions

Floor
Sep. 29 2022	Passed/agreed to in Senate: Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Unanimous Consent.